このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Psychodrama Group Therapy for Breakup Distress and Relationship Adjustment: A Randomized Trial

2026年6月14日 更新者:Filipe Ribeiro、Universidade do Porto

Psychodrama Group Therapy for Unresolved Breakup Distress and Dyadic Adjustment in Current Romantic Relationships: Study Protocol for a Randomized Controlled Trial

The purpose of this randomized controlled trial is to evaluate whether a psychodrama group therapy intervention can reduce unresolved breakup distress and improve dyadic adjustment in adults currently involved in romantic relationships who have experienced a significant previous breakup.

The main questions this study aims to answer are:

  • Does participation in psychodrama group therapy reduce breakup distress compared with a waiting-list control condition?
  • Does participation in psychodrama group therapy improve dyadic adjustment and relationship functioning compared with a waiting-list control condition?

The researchers will compare participants receiving the psychodrama group therapy intervention with participants in a waiting-list control condition to determine whether the intervention leads to greater improvements in breakup distress, dyadic adjustment, psychological functioning, relationship quality, and sexual satisfaction.

Participants will:

  • complete assessments at baseline, 16 weeks, and 42 weeks;
  • participate in a 15-session weekly psychodrama group therapy program (intervention group only);
  • complete questionnaires assessing breakup distress, dyadic adjustment, psychological outcomes, relationship quality, and sexual satisfaction.

調査の概要

詳細な説明

Romantic relationship breakups are common life events that may have substantial emotional and relational consequences. While many individuals adapt successfully over time, some continue to experience unresolved breakup distress characterized by persistent emotional suffering, difficulties processing the loss, and challenges integrating the experience into their personal and relational lives. Emerging evidence suggests that unresolved distress following a previous romantic breakup may negatively affect the quality of subsequent romantic relationships, including communication, intimacy, trust, emotional regulation, and overall dyadic adjustment.

Despite increasing recognition of the psychological and relational impact of romantic breakups, there is a limited evidence base regarding interventions specifically designed to address unresolved breakup distress. Furthermore, randomized controlled trials evaluating psychodrama interventions in this context remain scarce. Psychodrama is an experiential and action-oriented psychotherapy approach developed by Jacob Levy Moreno that uses dramatization, role-playing, role reversal, and other action methods to facilitate emotional expression, interpersonal insight, and behavioral change. Through the exploration of past and present relational experiences, psychodrama may help individuals process unresolved emotions associated with previous relationships, recognize maladaptive relational patterns, and develop more adaptive ways of relating in current relationships.

The present study was designed to evaluate the effectiveness of a manualized psychodrama group therapy program for adults currently involved in romantic relationships who continue to experience unresolved distress related to a significant previous breakup. The intervention was developed based on psychodramatic theory and clinical practice and focuses on emotional processing of previous relationship losses, exploration of attachment and relational patterns, enhancement of emotional communication, strengthening of intimacy and trust, and promotion of healthier dyadic functioning in current romantic relationships.

This study employs a randomized controlled design comparing a psychodrama group therapy intervention with a waiting-list control condition. The intervention consists of 15 weekly group sessions delivered in a closed-group format by trained psychodrama practitioners. Sessions follow the traditional psychodramatic structure of warm-up, dramatization, and sharing and progressively address themes including relational history, attachment experiences, breakup distress, grief processes, self-esteem, emotional communication, jealousy, emotional security, relational repair, intimacy, and relational role reconstruction.

In addition to evaluating clinical outcomes, the study aims to contribute to the methodological development of psychodrama research by implementing a structured intervention protocol and examining both quantitative and qualitative indicators of therapeutic change. Findings from this trial may contribute to a better understanding of the role of psychodrama in addressing unresolved breakup distress and promoting healthier functioning in subsequent romantic relationships. The results may also inform the development of evidence-based interventions targeting the long-term emotional and relational consequences of romantic relationship dissolution.

研究の種類

介入

入学 (推定)

42

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Porto District
      • Porto、Porto District、ポルトガル、4200-135
        • 募集
        • Faculty of Psychology and Education Sciences at the University of Porto
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Filipe N Ribeiro, PhD Student
        • 副調査官:
          • Mariana V Martins, PhD
        • 副調査官:
          • Filipa M Vieira, PhD

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Age 18 years or older;
  • Currently involved in a romantic relationship for at least 6 months;
  • History of at least one significant previous romantic relationship breakup;
  • Presence of breakup distress related to a previous romantic breakup and/or difficulties in current dyadic adjustment;
  • Ability and willingness to provide written informed consent.

Exclusion Criteria:

  • Presence of severe mental disorder that may interfere with participation in group psychotherapy;
  • Severe active substance dependence;
  • Current severe relational violence;
  • Inability or unwillingness to provide written informed consent;
  • Any clinical condition that, in the opinion of the research team, may compromise safe participation in the intervention.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Psychodrama Group Therapy
Participants assigned to this arm will receive a structured psychodrama group therapy intervention consisting of 15 weekly sessions delivered in a closed-group format. Sessions are facilitated by trained psychodrama practitioners and focus on emotional processing of unresolved breakup distress, exploration of relational and attachment patterns, emotional communication, intimacy, trust, and dyadic adjustment in current romantic relationships.
A manualized psychodrama group therapy program delivered in 15 weekly sessions of approximately 90-120 minutes. The intervention is based on Morenian psychodrama principles and uses techniques such as role reversal, soliloquy, mirroring, sociometry, sculpting, and dramatization to facilitate emotional processing of previous romantic relationship losses and promote healthier functioning in current romantic relationships. The program is delivered in a closed-group format by trained psychodrama practitioners.
介入なし:Waiting-List Control
Participants assigned to this arm will remain on a waiting list during the study period and will not receive the psychodrama intervention. They will complete all study assessments at the same time points as the intervention group and will be offered the opportunity to participate in the psychodrama program after completion of the follow-up assessments.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Breakup Distress
時間枠:Baseline, 16 weeks, and 42 weeks
Assessment of breakup-related emotional distress using the Breakup Distress Scale (BDS). The BDS is a 16-item self-report measure assessing emotional distress associated with a previous romantic relationship breakup. Higher scores indicate greater breakup distress.
Baseline, 16 weeks, and 42 weeks
Change in Dyadic Adjustment
時間枠:Baseline, 16 weeks, and 42 weeks
Assessment of relationship functioning using the Revised Dyadic Adjustment Scale (RDAS). The RDAS is a 14-item self-report measure evaluating overall dyadic adjustment and the dimensions of consensus, satisfaction, and cohesion within the current romantic relationship. Higher scores indicate better dyadic adjustment.
Baseline, 16 weeks, and 42 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Psychological Functioning
時間枠:Baseline, 16 weeks, and 42 weeks
Assessment of psychological functioning using the Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM). The CORE-OM is a 34-item self-report measure assessing subjective well-being, psychological symptoms, social functioning, and risk-related behaviors. Higher scores indicate greater psychological distress and impairment.
Baseline, 16 weeks, and 42 weeks
Change in Perceived Relationship Quality
時間枠:Baseline, 16 weeks, and 42 weeks
Assessment of perceived relationship quality using the Perceived Relationship Quality Components Inventory (PRQC). The PRQC is an 18-item self-report measure assessing satisfaction, commitment, intimacy, trust, passion, and love within the current romantic relationship. Higher scores indicate better perceived relationship quality.
Baseline, 16 weeks, and 42 weeks
Change in Sexual Satisfaction
時間枠:Baseline, 16 weeks, and 42 weeks
Assessment of sexual satisfaction using the Global Measure of Sexual Satisfaction (GMSEX). The GMSEX is a 5-item self-report measure assessing overall satisfaction with the sexual relationship with the current partner. Higher scores indicate greater sexual satisfaction.
Baseline, 16 weeks, and 42 weeks

その他の成果指標

結果測定
メジャーの説明
時間枠
Therapeutic Change as Reported by Participants
時間枠:During sessions 1-15 and at 16 weeks (intervention group only)
Assessment of participants' perceived therapeutic change using the Personal Questionnaire (PQ), an individualized measure in which participants identify and rate personal problems they wish to address during therapy. Lower scores indicate improvement in identified problems.
During sessions 1-15 and at 16 weeks (intervention group only)
Helpful and Hindering Aspects of Therapy
時間枠:After each intervention session 1-15 (intervention group only)
Assessment of participants' perceptions of helpful and unhelpful aspects of each therapy session using the Helpful Aspects of Therapy (HAT) questionnaire.
After each intervention session 1-15 (intervention group only)
Participant Experience of Therapeutic Change
時間枠:16 weeks and 42 weeks (intervention group only)
Assessment of participants' experiences of change during therapy using the Client Change Interview (CCI), a semi-structured interview exploring perceived changes, contributing factors, and helpful or unhelpful aspects of treatment.
16 weeks and 42 weeks (intervention group only)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディディレクター:Mariana V Martins, PhD、Faculty of Psychology and Education Sciences at the University of Porto
  • スタディチェア:Filipa M Vieira, PhD、Faculty of Psychology and Education Sciences at the University of Porto
  • 主任研究者:Filipe N Ribeiro, PhD Student、Faculty of Psychology and Education Sciences at the University of Porto

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年9月23日

一次修了 (推定)

2026年9月1日

研究の完了 (推定)

2027年5月1日

試験登録日

最初に提出

2026年6月14日

QC基準を満たした最初の提出物

2026年6月14日

最初の投稿 (実際)

2026年6月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月18日

QC基準を満たした最後の更新が送信されました

2026年6月14日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • Ref.ª 2025-02-01b (CdE FPCEUP)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be shared due to the sensitive nature of the information collected and the need to protect participant confidentiality and privacy in accordance with ethical and data protection requirements.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する